XML 52 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 10 - Commitments and Contingencies (Details Textual)
12 Months Ended
Dec. 31, 2015
CAD
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
Employment [Member]      
Compensation CAD 19 $ 6,489  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares 75,000 75,000  
Stock Issued During Period, Value, Stock Options Exercised   $ 64,223  
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)   $ 53,519  
Consultant [Member] | Employee Stock Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 10 years 10 years  
Consultant [Member]      
Compensation | CAD CAD 1,000    
Stock Issued During Period, Value, Stock Options Exercised   $ 42,816  
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)   $ 35,680  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares 100,000 100,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares   4,167  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares   $ 1  
Research and Development Expense   $ 10,861 $ 11,650
Operating Leases, Rent Expense   $ 430  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares   1,707,744  
Research and Development Expense   $ 456,274 $ 191,069